Bill Snyder Archive — Page 106 of 121

Two young children wearing blue gloves examine a large model human brain at a hands-on science event. The child in an orange shirt reaches toward the brain while a child in a red dress looks on.
February 20, 2014

Event set to reveal wonders, mysteries of the brain

“Brain Blast,” a half day of free, hands-on activities for children and adults, will be held from 9 a.m. to 1 p.m., Saturday, March 1, at Vanderbilt Health One Hundred Oaks, 719 Thompson Lane.

Portrait of a smiling man wearing glasses and a gray collared shirt in a laboratory setting.
February 20, 2014

Noted clinical pharmacologist Kim to speak

Richard Kim, M.D., former professor of Medicine and clinical pharmacologist at Vanderbilt, will deliver this year’s Grant R. Wilkinson Distinguished Lecture in Clinical Pharmacology at 8 a.m. Thursday, Feb. 27, in 208 Light Hall.

microscope
February 13, 2014

Major grant creates clinical research network

Vanderbilt University Medical Center has received an 18-month, $6.9 million award to set up a Clinical Data Research Network (CDRN) that can reach millions of patients and speed the translation of research findings into clinical practice.

Speaker gesturing with one hand while presenting in a lecture hall; a projected screen is visible behind him.
February 6, 2014

Discovery Lecture sheds light on properties of motion

Ron Vale, Ph.D., co-discoverer of the molecular “motor” kinesin, spent the first 10 minutes of his Flexner Discovery Lecture last week talking not about science, but about science communication.

Open glass bottle spilling translucent golden softgel capsules onto a white surface.
February 6, 2014

Antioxidants promising for rare disorder

The antioxidant vitamin E prevented the buildup of toxic products in a model of a rare genetic disorder, suggesting new strategies for therapeutic development.

Close-up of multiple hypodermic syringes arranged diagonally, with transparent barrels, black measurement markings, teal needle hubs, and a red strip crossing the image.
February 5, 2014

Discovery may pave way for RSV vaccine

Vanderbilt University scientists have contributed to a major finding, reported this week in the journal Nature, which could lead to the first effective vaccine against respiratory syncytial virus (RSV), a significant cause of infant mortality.